FFPRHC Guidance (January 2004). The copper intrauterine device as long-term contraception.
This Guidance provides information for clinicians providing women with copper-bearing intrauterine devices as long-term contraception. A key to the grades of recommendations, based on levels of evidence, is given at the end of this document. Details of the methods used by the Clinical Effectiveness Unit (CEU) in developing this Guidance and evidence tables summarising the research basis of the recommendations are available on the Faculty website (www.ffprhc.org.uk). Abbreviations (in alphabetical order) used include: acquired immune deficiency syndrome (AIDS); actinomyces-like organisms (ALOs); automated external defibrillator (AED); blood pressure (BP); British National Formulary (BNF); confidence interval (CI); copper-bearing intrauterine contraceptive device (IUD); emergency contraception (EC); Faculty Aid to Continuing Professional Development Topic (FACT); levonorgestrel-releasing intrauterine system (IUS); human immunodeficiency virus (HIV); Medicines and Healthcare products Regulatory Agency (MHRA); non-steroidal antiinflammatory drugs (NSAIDs); odds ratio (OR); pelvic inflammatory disease (PID); relative risk (RR); Royal College of Obstetricians and Gynaecologists (RCOG); Scottish Intercollegiate Guidelines Network (SIGN); sexually transmitted infection (STI); termination of pregnancy (TOP); World Health Organization (WHO); WHO Medical Eligibility Criteria (WHOMEC); WHO Selected Practice Recommendations (WHOSPR).
Clinical Effectiveness Unit, Faculty of Family Planning and Reproductive Health Care, Royal College of Obstetricians and Gynaecologists, 27 Sussex Place, Regent's Park, London NW1 4RG, UK. ffp.ceu@abdn.ac.uk
Gillian
G
Penney
Susan
S
Brechin
Alison
A
de Souza
Urszula
U
Bankowska
Toni
T
Belfield
Maggie
M
Gormley
Mary
M
Olliver
Naomi
N
Hampton
Ruth
R
Howlett-Shipley
Sarah
S
Hughes
Noel
N
Mack
Paul
P
O'Brien
Sam
S
Rowlands
Karen
K
Trewinnard
D003257:Consumer Product Safety / Q000592:standards; D000075202:Contraindications; D003376:Counseling / Q000592:standards; D020878:Device Removal / Q000592:standards; D005193:Family Planning Services / Q000592:standards*; D005260:Female; D006801:Humans; D007434:Intrauterine Devices; D007435:Intrauterine Devices, Copper / Q000009:adverse effects / Q000592:standards* / Q000706:statistics & numerical data; D008599:Menstruation Disturbances / Q000209:etiology; D010353:Patient Education as Topic / Q000592:standards; D049590:Postpartum Period; D011247:Pregnancy; D018456:Reproductive Medicine / Q000592:standards*; D018570:Risk Assessment; D012749:Sexually Transmitted Diseases / Q000175:diagnosis; D006113:United Kingdom; D014932:Women's Health Services / Q000592:standards*